Protease-activated receptor-2 (PAR-2): Structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes

被引:48
|
作者
Maryanoff, BE [1 ]
Santulli, RJ [1 ]
McComsey, DF [1 ]
Hoekstra, WJ [1 ]
Hoey, K [1 ]
Smith, CE [1 ]
Addo, M [1 ]
Darrow, AL [1 ]
Andrade-Gordon, P [1 ]
机构
[1] RW Johnson Pharmaceut Res Inst, Drug Discovery, Spring House, PA 19477 USA
关键词
protease-activated receptor; agonist peptides; intracellular calcium; structure-activity; tethered-ligand receptor; transfected cells;
D O I
10.1006/abbi.2000.2207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protease-activated receptor-a (PAR-S) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (-/-) cell line transfected with either human PAR-8 or PAR-1. A "directed" library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-8 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-S. The most potent agonist peptides (EC50 = 2-4 muM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05-0.35 muM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 muM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Re and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists. (C) 2001 Academic Press.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 50 条
  • [1] PROTEASE-ACTIVATED RECEPTOR-2 (PAR-2) IN THE PATHOGENESIS OF OSTEOARTHRITIS
    Ferrell, William R.
    Kelso, Elizabeth B.
    Lockhart, John C.
    Burns, Elizabeth
    Plevin, Robin
    McInnes, Iain B.
    RHEUMATOLOGY, 2011, 50 : 90 - 90
  • [2] Activation of protease-activated receptor-2 (PAR-2) induces cardioprotection in anaesthetised mice
    Lim, SY
    Kane, KA
    Kennedy, S
    Wainwright, CL
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) : 858 - 858
  • [3] Modulation of serum IgE by protease-activated receptor-2 (PAR-2).
    Davis, M
    Sigounas, A
    Shibata, Y
    Metzger, WJ
    Henriksen, RA
    FASEB JOURNAL, 1999, 13 (07): : A1472 - A1472
  • [4] Protease-activated receptor-2 (PAR-2) as a potential therapeutic target
    Kanke, T
    Takizawa, T
    Kabeya, M
    Kawabata, A
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 64P - 64P
  • [5] Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation
    Sanchez-Hernandez, Pedro Ernesto
    Ramirez-Duenas, Maria Guadalupe
    Albarran-Somoza, Benibelks
    Garcia-Iglesias, Trinidad
    del Toro-Arreola, Alicia
    Franco-Topete, Ramon
    Daneri-Navarro, Adrian
    GYNECOLOGIC ONCOLOGY, 2008, 108 (01) : 19 - 26
  • [6] Protease-activated receptor-2 (PAR-2)-related peptides induce tear secretion in rats: Involvement of PAR-2 and non-PAR-2 mechanisms
    Nishikawa, H
    Kawai, K
    Tanaka, M
    Ohtani, H
    Tanaka, S
    Kitagawa, C
    Nishida, M
    Abe, T
    Araki, H
    Kawabata, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (01): : 324 - 331
  • [7] Protease-activated receptor-2 (PAR-2): a potential new target in arthritis
    Ferrell, William R.
    Lockhart, John C.
    Plevin, Robin
    DRUGS OF THE FUTURE, 2008, 33 (03) : 241 - 248
  • [8] Activation of protease-activated receptor-2 (PAR-2) induces lymphocyte adhesion in intact mouse arteries
    Lim, SY
    Kane, KA
    Kennedy, S
    Wainwright, CL
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) : 857 - 857
  • [9] Activation of protease-activated receptor-2 (PAR-2) triggers mucin secretion in the rat sublingual gland
    Kawabata, A
    Morimoto, N
    Nishikawa, H
    Kuroda, R
    Oda, Y
    Kakehi, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (01) : 298 - 302
  • [10] Structure-function analysis of protease-activated receptor 4 tethered ligand peptides - Determinants of specificity and utility in assays of receptor function
    Faruqi, TR
    Weiss, EJ
    Shapiro, MJ
    Huang, W
    Coughlin, SR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) : 19728 - 19734